Gene · 6660
Papers1,923
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 1,923
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Brain insulin receptor gene network shapes risk for metabolic disease after early-life stress in women. | Commun Biol | 2025 | 41006755 | PubTator, text mining | PubMed |
| Circular RNA-based protein replacement therapy mitigates osteoarthritis in male mice. | Nat Commun | 2025 | 41006212 | PubTator, text mining | PubMed |
| Correction: Functional characterization of SOX5 variant causing Lamb-Shaffer syndrome and literature review of variants in the SOX5 gene. | Orphanet J Rare Dis | 2025 | 40999496 | PubTator, text mining | PubMed |
| Yes-associated protein 1 in cancer: bridging mechanical transduction and epigenetic regulation. | Cancer Biol Ther | 2025 | 40977060 | PubTator, text mining | PubMed |
| Stem Cells in Regenerative Medicine: A Journey from Adult Stem Cells to Induced Pluripotent Cells. | Int J Mol Sci | 2025 | 40943178 | PubTator, text mining | PubMed |
| Detecting suicide risk in bipolar disorder patients from lymphoblastoid cell lines genetic signatures. | Transl Psychiatry | 2025 | 40903457 | PubTator, text mining | PubMed |
| The Interface of Gene Editing with Regenerative Medicine. | Engineering (Beijing) | 2025 | 40881775 | PubTator, text mining | PubMed |
| Homologous Recombination Deficiency in Ovarian and Breast Cancers: Biomarkers, Diagnosis, and Treatment. | Curr Issues Mol Biol | 2025 | 40864792 | PubTator, text mining | PubMed |
| MiR-135a-3p inhibits the progression of prostate cancer by targeting TLR4. | Cancer Biol Ther | 2025 | 40843910 | PubTator, text mining | PubMed |
| Integration of Single-Cell RNA and Bulk RNA Sequencing Reveals Cellular Heterogeneity and Identifies Survival-Associated Regulatory Networks in Glioblastoma. | IET Syst Biol | 2025 | 40804738 | PubTator, text mining | PubMed |
| Regulatory roles of 13 types of RNA modifications in osteoarthritis: based on bulk and single-cell RNA analysis. | 3 Biotech | 2025 | 40771586 | PubTator, text mining | PubMed |
| Targeting AKR1B1 inhibits metabolic reprogramming to reverse systemic therapy resistance in hepatocellular carcinoma. | Signal Transduct Target Ther | 2025 | 40750772 | PubTator, text mining | PubMed |
| Dihydroartemisinin targets the miR-497-5p/SOX5 axis to suppress tumor progression in non-small cell lung cancer. | Front Pharmacol | 2025 | 40697663 | PubTator, text mining | PubMed |
| Blocking calcium-MYC regulatory axis inhibits early dedifferentiation of chondrocytes and contributes to cartilage regeneration. | Stem Cell Res Ther | 2025 | 40660304 | PubTator, text mining | PubMed |
| Residual Breast Cancer Cells Co-opt SOX5-driven Endochondral Ossification to Maintain Dormancy. | bioRxiv | 2025 | 40654671 | PubTator, text mining | PubMed |
| Combined TGF-β3 and FGF-2 Stimulation Enhances Chondrogenic Potential of Ovine Bone Marrow-Derived MSCs. | Cells | 2025 | 40643533 | PubTator, text mining | PubMed |
| Transcriptomics and chromatin accessibility signatures define the cervical-thoracic boundary along the vertebrate axis. | Dev Biol | 2025 | 40516645 | PubTator, text mining | PubMed |
| Functional characterization of SOX5 variant causing Lamb-Shaffer syndrome and literature review of variants in the SOX5 gene. | Orphanet J Rare Dis | 2025 | 40500800 | PubTator, text mining | PubMed |
| Expression and potential regulatory mechanism of cellular senescence-related genes in Alzheimer's disease based on single-cell and bulk RNA datasets. | Front Neurosci | 2025 | 40470298 | PubTator, text mining | PubMed |
| Dissecting small cell carcinoma of the esophagus ecosystem by single-cell transcriptomic analysis. | Mol Cancer | 2025 | 40375239 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6660/papers?page=3